Crestwood Advisors Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,958
Closed -$201K 276
2022
Q2
$201K Buy
+5,958
New +$209K 0.01% 248
2022
Q1
Sell
-13,744
Closed -$419K 303
2021
Q4
$419K Sell
13,744
-1,544
-10% -$50.3K 0.01% 219
2021
Q3
$501K Sell
15,288
-5,956
-28% -$191K 0.01% 198
2021
Q2
$643K Buy
+21,244
New +$699K 0.02% 182

Other funds holding OGN

Crestwood Advisors Group's OGN Position: Q3 2022 in Review

Crestwood Advisors Group sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 5,958 shares — an estimated $201K sold.

Crestwood Advisors Group first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $643K in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Crestwood Advisors Group reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Crestwood Advisors Group sold 5,958 Organon & Co shares in Q3 2022, an estimated $201K.
  • Crestwood Advisors Group first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Crestwood Advisors Group's Organon & Co position peaked at $643K in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Crestwood Advisors Group's 13F filing for Q3 2022, filed 26 Oct 2022.